MEDINDIA EXPORT in Nagpur

Products

What We Do

Rybelsus Semaglutide 3mg Tablets

Rybelsus Semaglutide 3mg Tablets fast delivery in UK,USA,SINGAPORE,AUSTRALIA-MEDINDIA EXPORT ₹ 4000 / Stripe Get Latest Price Form Tablets Packaging size 10*10 Tablets Packaging Type Strip Composition Semaglutide Brand RYBELSUS Manufacturer NOVO NORDISK Usuage to treat type 2 diabetes Country of Origin Made in India Rybelsus is a brand-name prescription medication that's FDA-approved to treat type 2 diabetes. The drug helps control blood sugar in adults when used with diet and exercise. Type 2 diabetes is a condition in which your blood sugar level becomes too high due to problems with a hormone called insulin.

Send Message

WEIGHT LOSS MEDICINES

Fitaro 2.4 mg injection

₹ 9876 / Piece Get Latest Price Form Injection Packaging Type Vial Brand Fitaro 2.4 mg Manufacturer Incepta pharma Usage / Application Personal Prescription/Non prescription Non prescription Shelf Life 6 months Also gives Pharmaceutical Third Party Manufacturing Minimum order quantity: 10 Piece Semaglutide reduces blood glucose in a glucose dependent manner by simulating insulin secretion and lowering glucagon secretion when blood glucose is high. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying. During hypoglycemia, Semaglutide diminishes insulin secretion and does not impair glucagon secretion. Semaglutide reduces body weight and body fat mass by an overall reduced appetite.

Send Message

WEIGHT LOSS MEDICINES

Fitaro 0.5 mg Injection

Fitaro 0.5 mg Injection exporter in UK,USA,SINGAPORE,AUSTRALIA-MEDINDIA EXPORT ₹ 8633 / Piece Get Latest Price Form Injection Packaging Type Vial Brand Fitaro 0.5 Manufacturer Incepta pharma Usage / Application Personal Prescription/Non prescription Non prescription Shelf Life 6 months Also gives Pharmaceutical Third Party Manufacturing Minimum order quantity: 10 Piece Semaglutide reduces blood glucose in a glucose dependent manner by simulating insulin secretion and lowering glucagon secretion when blood glucose is high. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying. During hypoglycemia, Semaglutide diminishes insulin secretion and does not impair glucagon secretion. Semaglutide reduces body weight and body fat mass by an overall reduced appetite.